Cargando…
Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
BACKGROUND: There is an unmet need for noninvasive markers specific for kidney transplant rejection. Such a marker may eventually overcome the need for a transplant biopsy. In this pilot study, the potential of circulating cell-free nucleosomes (CCFN) to serve as a biomarker for kidney transplant re...
Autores principales: | Verhoeven, Jeroen G. H. P., Baan, Carla C., Peeters, Annemiek M. A., Clahsen-van Groningen, Marian C., Nieboer, Daan, Herzog, Mariëlle, Eccleston, Marc, Hesselink, Dennis A., Boer, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879674/ https://www.ncbi.nlm.nih.gov/pubmed/33573704 http://dx.doi.org/10.1186/s13148-020-00969-4 |
Ejemplares similares
-
Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023) -
Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2021) -
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018) -
Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022) -
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)